4,419 results on '"*PERIPARTUM cardiomyopathy"'
Search Results
2. Peripartum Cardiomyopathy; Understanding and Improving Outcomes-A Systematic Review.
- Author
-
Ganiyu, Shakirat, Lawal, Taiwo Akeem, and Petrie, Sarah
- Subjects
- *
PARTICULATE matter , *MATERNAL mortality , *BROMOCRIPTINE , *GENETIC mutation , *ENVIRONMENTAL policy , *PERIPARTUM cardiomyopathy - Abstract
Background: Peripartum cardiomyopathy (PPCM) presents a significant global health challenge, contributing substantially to maternal morbidity and mortality worldwide. Despite ongoing research efforts, the multifaceted nature of PPCM, encompassing genetic, environmental, and clinical factors, necessitates a comprehensive understanding to improve patient outcomes effectively. Aims: This systematic review aims to synthesise current knowledge on PPCM aetiology, risk factors, diagnosis, therapeutic interventions, and prognostic indicators, highlighting recent advancements and potential avenues for future research and clinical management. By addressing key aspects such as genetic predispositions, environmental influences, diagnostic strategies, therapeutic modalities, and global disparities, this review seeks to provide insights that can inform interdisciplinary approaches and ultimately enhance the care and outcomes of affected patients on a global scale. Methodology: Narrative, qualitative systematic review of current literature Results: This systematic review delved into the multifaceted landscape of PPCM, revealing genetic, environmental, and clinical intricacies. Key findings included the identification of TTN truncating mutations as a significant genetic predisposition, prompting personalised medical interventions. Environmental factors, such as PM2.5 exposure, intersected with clinical dynamics, highlighting the need for interdisciplinary cooperation in healthcare and environmental policy. Additionally, studies emphasised the importance of timely diagnosis, global disparities in PPCM incidence, and the potential for personalised treatments like bromocriptine and targeted genetic therapies. Conclusion: This review illuminated the complexity of peripartum cardiomyopathy and provides a roadmap for future research and clinical management, advocating for holistic approaches to improve patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
3. A case report of reversible left ventricular dysfunction due to azathioprine hypersensitivity syndrome.
- Author
-
Lüscher, Daniel, Maeder, Micha T, and Scheler, Eva
- Subjects
LEFT ventricular dysfunction ,CARDIAC magnetic resonance imaging ,AZATHIOPRINE ,CHEST pain ,PERIPARTUM cardiomyopathy ,ALLERGIES - Abstract
Background Hypersensitivity reaction is a rare side effect during immunosuppressive treatment with azathioprine (AZA). Some cases of cardiac involvement have already been reported but causality is notoriously difficult to prove. Case summary We present the case of a 68-year-old man with two episodes of reversible left ventricular (LV) dysfunction. One month after treatment initiation with AZA, he developed non-specific symptoms, including mild chest pain. In the context of elevated cardiac biomarkers and markers of inflammation, echocardiography showed depressed systolic LV function. Biventricular dysfunction was shown on cardiac magnetic resonance imaging (CMR), but neither myocardial oedema nor late gadolinium enhancement was documented. There was full recovery of LV function after AZA discontinuation. Very similar clinical course and echocardiography findings were observed early after restarting AZA treatment. After definitive cessation of AZA, systolic LV function recovered again and remained stable throughout long-term follow-up. Discussion Hypersensitivity reaction with cardiac involvement due to AZA is rare. The exact mechanisms underlying AZA-related cardiac dysfunction are still not completely understood, and causality is often difficult to prove. However, because of re-exposure to the drug, which, considered retrospectively, was inappropriate, the effect was clearly apparent in our patient. Knowledge of this potentially life-threatening side effect of AZA treatment is important. AZA must be discontinued promptly if there is any evidence of hypersensitivity reaction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Temporary mechanical support in the peripartum patient as a bridge to postpartum recovery: A report of three cases.
- Author
-
Jimenez, Yomary, Elzeneini, Mohammed, Siddique, Nasir F., Vilaro, Juan, Aranda, Juan Jr, Al‐Ani, Mohammad, Park, Ki, Wen, Tony S., Egerman, Robert S., Jeng, Eric I., Ahmed, Mustafa M., and Parker, Alex M.
- Subjects
- *
PERIPARTUM cardiomyopathy , *ARTIFICIAL blood circulation , *HEART assist devices , *CARDIOGENIC shock , *EXTRACORPOREAL membrane oxygenation , *BRIDGES - Abstract
Cardiogenic shock (CS) is a severe complication of peripartum cardiomyopathy (PPCM). Patients with deteriorating CS often require temporary mechanical circulatory support. In PPCM, this can be used as a bridge to postpartum recovery or bridge to decision. The outcomes are unclear, especially if prolonged utilization is required. We present a case series of three patients with PPCM in deteriorating CS who were successfully supported with a ventricular assist device or veno‐arterial extracorporeal membrane oxygenation as a bridge to postpartum recovery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Diuretics in pregnancy: Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC).
- Author
-
van der Zande, Johanna A., Greutmann, Matthias, Tobler, Daniel, Ramlakhan, Karishma P., Cornette, Jerome M. J., Ladouceur, Magalie, Collins, Nicholas, Adamson, Dawn, Paruchuri, Vijaya P., Hall, Roger, Johnson, Mark R., and Roos‐Hesselink, Jolien W.
- Subjects
- *
PERIPARTUM cardiomyopathy , *HEART failure , *SMALL for gestational age , *DIURETICS , *HEART valve diseases , *HEART diseases in women , *CARDIOVASCULAR agents - Abstract
Aims: Data on diuretic use in pregnancy are limited and inconsistent, and consequently it remains unclear whether they can be used safely. Our study aims to evaluate the perinatal outcomes after in‐utero diuretic exposure. Methods and results: The Registry Of Pregnancy And Cardiac disease (ROPAC) is a prospective, global registry of pregnancies in women with heart disease. Outcomes were compared between women who used diuretics during pregnancy versus those who did not. Multivariable regression analysis was used to assess the impact of diuretic use on the occurrence of congenital anomalies and foetal growth. Diuretics were used in 382 (6.7%) of the 5739 ROPAC pregnancies, most often furosemide (86%). Age >35 years (odds ratio [OR] 1.5, 95% confidence interval [CI] 1.2–2.0), other cardiac medication use (OR 5.4, 95% CI 4.2–6.9), signs of heart failure (OR 1.7, 95% CI 1.2–2.2), estimated left ventricular ejection fraction <40% (OR 2.9, 95% CI 2.0–4.2), New York Heart Association class >II (OR 3.4, 95% CI 2.3–5.1), valvular heart disease (OR 6.3, 95% CI 4.7–8.3) and cardiomyopathy (OR 3.9, 95% CI 2.6–5.7) were associated with diuretic use during pregnancy. In multivariable analysis, diuretic use during the first trimester was not significantly associated with foetal or neonatal congenital anomalies (OR 1.3, 95% CI 0.7–2.6), and diuretic use during pregnancy was also not significantly associated with small for gestational age (OR 1.4, 95% CI 1.0–1.9). Conclusions: Our study does not conclusively establish an association between diuretic use during pregnancy and adverse foetal outcomes. Given these findings, it is essential to assess the risk–benefit ratio on an individual basis to guide clinical decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Preconception counselling in women of reproductive age attending cardiology clinics in Scotland.
- Author
-
Osmanska, Joanna, Jackson, Alice M., Simpson, Joanne, Adamson, Carly, Doherty, Daniel, Mamet, Helene, Moir, Lynsey, Walker, Niki L., Hogg, Duncan, and Simpson, Maggie
- Subjects
PRECONCEPTION care ,CHILDBEARING age ,COUNSELING ,MEDICAL personnel ,CARDIOVASCULAR diseases ,CARDIOLOGY ,PERIPARTUM cardiomyopathy ,GENDER medicine - Published
- 2024
- Full Text
- View/download PDF
7. Peripartum Cardiomyopathy: An Analysis of Clinical Profiles and Outcomes from a Tertiary Care Center in Northern India
- Author
-
Aqdas Mumtaz, Dheeraj Kela, Sangeeta Rai, and Vikas Agrawal
- Subjects
cardiogenic shock ,echocardiography ,fetal mortality ,peripartum cardiomyopathy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Objective: The present study was conducted to evaluate the clinical profile, and risk factors of peripartum cardiomyopathy (PPCM) and its association with maternal and fetal outcomes from a tertiary care center in Northern India. Methods: An observational cohort study was conducted on 19 pregnant females showing features of heart failure in the last month of pregnancy or 5 months postpartum. We analyzed the clinical profiles and outcomes in these women with PPCM. Results: The mean age of presentation was 27.9 years with a mean gestational age of 34.9 weeks. 68.4% were primigravida. The most commonly associated comorbidities were anemia and preeclampsia/eclampsia. Breathlessness was present in all women with maximum presenting with class IV breathlessness. The mean baseline ejection fraction (EF) was 34%. A significant change (P < 0.05) was observed in various echo parameters (left ventricular [LV] end diastolic volume; LV end systolic volume; LV strain; EF; right ventricular systolic excursion velocity; left atrial diameter) from baseline to 3 months. Maternal and fetal deaths occurred in 5.2% and 31.5% of subjects, respectively. Cardiogenic shock and significantly reduced EF were associated with adverse fetal and maternal outcomes. Conclusion: The majority of the study participants were young primigravidas with preeclampsia and anemia being strongly associated risk factors. PPCM with poor LVEF and shock is associated with adverse fetal and maternal outcomes. Larger studies with a higher number of patients are needed to study PPCM in detail in the Indian subset.
- Published
- 2024
- Full Text
- View/download PDF
8. Risk Factors and Clinical Features of Peripartum Cardiomyopathy in a Chinese Population
- Author
-
Huang H, Ye Q, Xu Y, Tao B, Liu J, Xie T, and Zha L
- Subjects
peripartum cardiomyopathy ,risk factors ,clinical features ,early identification ,Medicine (General) ,R5-920 - Abstract
Hui Huang,1– 3,* Qing Ye,1– 4,* Yulan Xu,1– 3,* Baoming Tao,1– 3 Junlan Liu,1– 3 Tian Xie,1– 3 Lingfeng Zha1– 3 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 3Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 4School of Nursing, Wuhan University, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tian Xie; Lingfeng Zha, Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, People’s Republic of China, Tel +86-15972150162 ; +86-15827177185, Email xietian@hust.edu.cn; zhalf@hust.edu.cnPurpose: We investigated the risk factors and characteristic clinical features of peripartum cardiomyopathy (PPCM) to lay the groundwork for early identification, screening, diagnosis, and intervention in high-risk pregnant women.Patients and methods: A retrospective case-control study was conducted to analyze data from 44 patients with PPCM and 226 normal pregnant women from a Chinese population.Results: Significant differences were found between the groups in terms of various factors such as age, body mass index (BMI), heart rate, and medical history. Logistic regression models identified abnormal electrocardiography (OR=18.852), upper respiratory tract infection (OR=41.822), gestational hypertension (OR=18.188), and cesarean section (OR=8.394) as risk factors for PPCM. Common clinical features observed in patients with PPCM included cough, wheezing, and chest tightness (68.18%), left heart enlargement (56.82%) and valvular insufficiency (81.82%). Additionally, cardiotropic virus was detected in a subset of patients (43.18%) and NT-proBNP was elevated ≥ 400 pg/mL (81.82%).Conclusion: In the Chinese population, the presence of abnormal electrocardiograms during pregnancy, history of upper respiratory tract infection, gestational hypertension, and maternal choice of cesarean section suggest the possibility of PPCM development. Factors such as advanced age, family history of cardiovascular disease, gestational diabetes mellitus, eclampsia, anemia, and hypoproteinemia should be considered. Clinically, patients present with cough, wheezing, chest tightness, enlarged left heart, valvular insufficiency and NT-proBNP elevated ≥ 400 pg/mL. This study could serve as a valuable reference for medical practitioners for the early identification and screening of patients with PPCM.Keywords: peripartum cardiomyopathy, risk factors, clinical features, early identification
- Published
- 2024
9. Peripartum Cardiomyopathy: An Update
- Author
-
Shaikh, Nissar, Chanda, Arshad, Amara, Umm E, Nashrah, Umme, Almotawa, Aisha, Ummunnisa, Firdos, Haider, Farookh, Suliman, Mohamed, Shaikh, Nissar, editor, Ummunnisa, Firdos, editor, and Amara, Umm E, editor
- Published
- 2024
- Full Text
- View/download PDF
10. Adherence to heart failure treatment in patients with peripartum cardiomyopathy
- Author
-
Julian Hoevelmann, Karen Sliwa, Juel Maalouli Schaar, Olivia Briton, Michael Böhm, Markus R. Meyer, and Charle Viljoen
- Subjects
Liquid chromatography ,LV reverse remodelling ,Mass spectrometry ,Medication adherence ,Peripartum cardiomyopathy ,Risk stratification ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims Peripartum cardiomyopathy (PPCM) is characterized by left ventricular (LV) dysfunction developing towards the end of pregnancy or in the first months postpartum. Although about 60% of women with PPCM (the majority of which are prescribed evidence based heart failure [HF] medications) show LV recovery within 6 to 12 months, others remain with persistently impaired LV function. Poor adherence to medical therapy represents a major cause of avoidable hospitalizations, disability, and death in other cardiovascular conditions. In this study, we aimed to determine drug adherence to HF therapy among women with PPCM and to identify possible associations between drug adherence and LV recovery, functional status and psychological well‐being. Methods and results In this single‐centre, prospective, observational study, we included 36 consecutive women with PPCM. Adherence to HF treatment was assessed by (i) verifying the collection of pharmacy refills and (ii) using liquid chromatography high‐resolution mass spectrometry (LC‐HRMS). Participants were thereby classified as ‘adherent’ (i.e. all prescribed HF drugs were detectable by LC‐HRMS), ‘partially adherent’ (i.e. at least one prescribed drug detectable) or ‘non‐adherent’ (i.e. none of the prescribed drugs detectable). Health state index scores were assessed by EQ‐5D‐5L and HADS‐A/D (for anxiety/depression). Patients' median age was 32.4 years (IQR 27.6–36.1). At the adherence visit (which occurred at a median of 16 months [IQR 5–45] after PPCM diagnosis), prescription included beta‐blockers (77.8%), angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (75%), mineralocorticoid receptor antagonists (47.2%) and loop diuretics (95.2%). Less than two thirds of patients (63.9%) collected all their pharmacy refills in the 6 months prior to adherence visit. According to LC‐HRMS, 23.5% participants were classified as adherent, 53.0% as partially adherent, and 23.5% as non‐adherent. Adherence was associated with significantly lower LVEDD at follow‐up (47 mm [IQR 46–52), vs. 56 mm [IQR 49–64] with partial adherence, and 62 mm [IQR 55–64] with non‐adherence, P = 0.022), and higher LVEF at follow‐up (60% [IQR 41–65]), vs. partially adherence (46% [IQR 34–50]) and non‐adherence (41.0% [IQR 29–47], P = 014). Adherent patients had a lower overall EQ‐ 5D score (5.5 [IQR 5–7.5], vs. 6 [IQR 5–7] in partially adherent, and 10 [IQR 8–15] in non‐adherent patients, P = 0.032) suggestive of a better self‐rated health status. Conclusions Adherence to HF therapy was associated with favourable LV reverse remodelling in PPCM and better self‐rated health status. Our study highlights the importance of drug adherence for functional recovery. Drug adherence should be an important component of patient communication and specific interventions in PPCM.
- Published
- 2024
- Full Text
- View/download PDF
11. Recovery of left ventricular systolic function in peripartum cardiomyopathy: an observational study from rural Tanzania
- Author
-
Andrew Katende, Laurine Roos, Victor Z. Urio, Evance Mahundi, Victor Myovela, Dorcas Mnzava, Chipegwa Mlula, Christamonica Chitimbwa, Dominick M. Raphael, Winfrid Gingo, Fabian C. Franzeck, Daniel H. Paris, Luigia Elzi, Maja Weisser, and Martin Rohacek
- Subjects
Peripartum cardiomyopathy ,Recovery ,Left Ventricular Systolic Function ,Rural ,Tanzania ,Sub-Saharan Africa ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background The aim of this study was to evaluate the recovery rate of the left ventricular systolic function of women diagnosed with peripartum cardiomyopathy receiving specialized care in rural Tanzania. Methods In this observational study, women diagnosed with peripartum cardiomyopathy at a referral center in rural Tanzania between December 2015 and September 2021 were included. Women diagnosed between February and September 2021 were followed prospectively, those diagnosed between December 2015 and January 2021 were tracked back for a follow-up echocardiography. All participants received a clinical examination, a comprehensive echocardiogram, and a prescription of guideline-directed medical therapy. The primary outcome was recovery of the left ventricular systolic function (left ventricular ejection fraction > 50%). Results Median age of the 110 participants was 28.5 years (range 17–45). At enrolment, 49 (45%) participants were already on cardiac medication, 50 (45%) had severe eccentric hypertrophy of the left ventricle, and the median left ventricular ejection fraction was 30% (range 15–46). After a median follow-up of 8.98 months (IQR 5.72–29.37), 61 (55%) participants were still on cardiac medication. Full recovery of the left ventricular systolic function was diagnosed in 76 (69%, 95% CI 59.6–77.6%) participants. In the multivariate analysis, a higher left ventricular ejection fraction at baseline was positively associated with full recovery (each 5% increase; OR 1.7, 95% CI 1.10–2.62, p = 0.012), while higher age was inversely associated (each 10 years increase; OR 0.40, 95% CI 0.19–0.82, p = 0.012). Conclusion Left ventricular systolic function recovered completely in 69% of study participants with peripartum cardiomyopathy from rural Tanzania under specialized care.
- Published
- 2024
- Full Text
- View/download PDF
12. Connecting the Dots: Exploring the Interplay Between Preeclampsia and Peripartum Cardiomyopathy.
- Author
-
Gumilar, Khanisyah Erza, Rauf, Khairunnisa binti Abd, Akbar, Muhammad Ilham Aldika, Imanadha, Nareswari Cininta, Atmojo, Susetyo, Putri, Alisia Yuana, Dachlan, Erry Gumilar, Dekker, Gus, and Oğlak, Süleyman Cemil
- Subjects
- *
PERIPARTUM cardiomyopathy , *BLOOD pressure , *DISEASE susceptibility , *PREECLAMPSIA , *MATERNAL mortality , *ENDOTHELIUM diseases - Abstract
Preeclampsia and peripartum cardiomyopathy (PPCM) are significant obstetric problems that can arise during or after pregnancy. Both are known to be causes of maternal mortality and morbidity. Several recent studies have suggested a link between preeclampsia and the pathophysiology of PPCM. However, the common thread that connects the two has yet to be thoroughly and fully articulated. Here, we investigate the complex dynamics of preeclampsia and PPCM in this review. Our analysis focuses mainly on inflammatory and immunological responses, endothelial dysfunction as a shared pathway, and potential genetic predisposition to both diseases. To begin, we will look at how excessive inflammatory and immunological responses can lead to clinical symptoms of both illnesses, emphasizing the role of proinflammatory cytokines and immune cells in modifying vascular and tissue responses. Second, we consider endothelial dysfunction to be a crucial point at which endothelial damage and activation contribute to pathogenesis through increased vascular permeability, vascular dysfunction, and thrombus formation. Finally, we examine recent information suggesting genetic predispositions to preeclampsia and PPCM, such as genetic variants in genes involved in the management of blood pressure, the inflammatory response, and heart structural integrity. With this synergistic study, we seek to encourage more research and creative therapy solutions by emphasizing the need for an interdisciplinary approach to understanding and managing the connection between preeclampsia and PPCM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
- Author
-
Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, and Semsarian, Christopher
- Subjects
- *
HYPERTROPHIC cardiomyopathy , *CARDIAC magnetic resonance imaging , *CARDIOLOGY , *VENTRICULAR outflow obstruction , *PERIPARTUM cardiomyopathy - Abstract
The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy" have been updated with new evidence to guide clinicians. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
- Subjects
- *
HYPERTROPHIC cardiomyopathy , *CARDIAC magnetic resonance imaging , *CARDIOLOGY , *VENTRICULAR outflow obstruction , *HEART diseases , *PERIPARTUM cardiomyopathy , *CARDIOMYOPATHIES - Abstract
AIM: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy" have been updated with new evidence to guide clinicians. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Computational model captures cardiac growth in hypertensive pregnancies and in the postpartum period.
- Author
-
Kaissar, Molly S. and Yoshida, Kyoko
- Subjects
- *
PUERPERIUM , *PREGNANT women , *HYPERTENSION in pregnancy , *MULTISCALE modeling , *PERIPARTUM cardiomyopathy , *PREGNANCY - Abstract
Heart growth in the pregnant patient helps maintain cardiovascular function while supporting the growing fetus. However, in some cases, the cardiovascular demand of pregnancy can trigger life-threatening conditions, including hypertensive disorders of pregnancy and peripartum cardiomyopathy. The mechanisms that control heart growth throughout pregnancy are unclear, and treating these diseases remains elusive. We previously developed a computational model that accounts for hormonal and hemodynamic interactions throughout pregnancy and demonstrated its ability to capture realistic cardiac growth in normal rat pregnancy. In this study, we evaluated whether this model could capture heart growth beyond normal pregnancy. After further validation of our normal pregnancy predictions, we tested our model predictions of three rat studies of hypertensive pregnancies. We next simulated the postpartum period and examined the impact of lactation on cardiac growth in rats. We demonstrate that our multiscale model can capture cardiac growth associated with new-onset hypertension during pregnancy and lactation status in the postpartum period. We conclude by elaborating on the potential clinical utility of our model in the future. NEW & NOTEWORTHY: Our multiscale model predicts appropriate heart growth beyond normal pregnancy, including elevated heart weights in rats with induced hypertension during pregnancy and in lactating mice and decreased heart weight in nonlactating mice. Our model captures distinct mechanisms that result in similar organ-level growth, highlighting its potential to distinguish healthy from diseased pregnancy-induced growth. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Heart failure due to peripartum cardiomyopathy presenting in the first week of puerperium—A case series from Nepal.
- Author
-
Banmala, Sabin, Awal, Shila, Bata, Lokendra, Adhikari, Priya, Basnet, Sarita, and Chaudhary, Babita
- Subjects
- *
PERIPARTUM cardiomyopathy , *HEART failure , *BRAIN natriuretic factor , *PUERPERIUM , *SYMPTOMS , *ACUTE kidney failure - Abstract
Key Clinical Message: Peripartum cardiomyopathy (PPCM) is a rare cause of heart failure associated with pregnancy without any other known cause. With a prognosis that can vary from the complete recovery of left ventricular function to maternal mortality as well as recurrence with subsequent pregnancies, early diagnosis and treatment of PPCM is important in management. Bromocriptine treatment is beneficial effects on LVEF and mortality in women with severe acute PPCM in addition to standard heart failure therapy. However, further study is required to establish its effect in PPCM. Peripartum cardiomyopathy (PPCM) is a rare cause of heart failure associated with pregnancy without any other known cause. Most of the clinical presentation is similar to symptoms of advanced pregnancy making the diagnosis difficult. Reported are three patients who developed dyspnea, orthopnea, and dry cough during the first week of puerperium. On examination, bilateral lower limb edema and bilateral basal lung crepitation were present in all patients. Chest radiograph showed pulmonary edema in cases two and three, and pleural effusion in case one. All patients had reduced left ventricular ejection fraction and raised N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) levels. Case two developed PPCM in the background of left pyelonephritis. Case three was complicated by acute kidney injury. All patients were managed with bromocriptine, diuretics, beta‐blockers, ACE inhibitors, and fluid restriction. Hence, PPCM though rare should be considered as a differential in women presenting with features of heart failure in later months of pregnancy or within 5 months of delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Adherence to heart failure treatment in patients with peripartum cardiomyopathy.
- Author
-
Hoevelmann, Julian, Sliwa, Karen, Schaar, Juel Maalouli, Briton, Olivia, Böhm, Michael, Meyer, Markus R., and Viljoen, Charle
- Subjects
LIQUID chromatography-mass spectrometry ,PERIPARTUM cardiomyopathy ,HEART failure patients ,ANGIOTENSIN-receptor blockers ,PATIENT compliance - Abstract
Aims: Peripartum cardiomyopathy (PPCM) is characterized by left ventricular (LV) dysfunction developing towards the end of pregnancy or in the first months postpartum. Although about 60% of women with PPCM (the majority of which are prescribed evidence based heart failure [HF] medications) show LV recovery within 6 to 12 months, others remain with persistently impaired LV function. Poor adherence to medical therapy represents a major cause of avoidable hospitalizations, disability, and death in other cardiovascular conditions. In this study, we aimed to determine drug adherence to HF therapy among women with PPCM and to identify possible associations between drug adherence and LV recovery, functional status and psychological well‐being. Methods and results: In this single‐centre, prospective, observational study, we included 36 consecutive women with PPCM. Adherence to HF treatment was assessed by (i) verifying the collection of pharmacy refills and (ii) using liquid chromatography high‐resolution mass spectrometry (LC‐HRMS). Participants were thereby classified as 'adherent' (i.e. all prescribed HF drugs were detectable by LC‐HRMS), 'partially adherent' (i.e. at least one prescribed drug detectable) or 'non‐adherent' (i.e. none of the prescribed drugs detectable). Health state index scores were assessed by EQ‐5D‐5L and HADS‐A/D (for anxiety/depression). Patients' median age was 32.4 years (IQR 27.6–36.1). At the adherence visit (which occurred at a median of 16 months [IQR 5–45] after PPCM diagnosis), prescription included beta‐blockers (77.8%), angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (75%), mineralocorticoid receptor antagonists (47.2%) and loop diuretics (95.2%). Less than two thirds of patients (63.9%) collected all their pharmacy refills in the 6 months prior to adherence visit. According to LC‐HRMS, 23.5% participants were classified as adherent, 53.0% as partially adherent, and 23.5% as non‐adherent. Adherence was associated with significantly lower LVEDD at follow‐up (47 mm [IQR 46–52), vs. 56 mm [IQR 49–64] with partial adherence, and 62 mm [IQR 55–64] with non‐adherence, P = 0.022), and higher LVEF at follow‐up (60% [IQR 41–65]), vs. partially adherence (46% [IQR 34–50]) and non‐adherence (41.0% [IQR 29–47], P = 014). Adherent patients had a lower overall EQ‐ 5D score (5.5 [IQR 5–7.5], vs. 6 [IQR 5–7] in partially adherent, and 10 [IQR 8–15] in non‐adherent patients, P = 0.032) suggestive of a better self‐rated health status. Conclusions: Adherence to HF therapy was associated with favourable LV reverse remodelling in PPCM and better self‐rated health status. Our study highlights the importance of drug adherence for functional recovery. Drug adherence should be an important component of patient communication and specific interventions in PPCM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Pregnancy and cardiac maternal outcomes in women with inherited cardiomyopathy: interest of the CARPREG II risk score.
- Author
-
Wallet, Thomas, Legrand, Lise, Isnard, Richard, Gandjbakhch, Estelle, Pousset, Françoise, Proukhnitzky, Julie, Dommergues, Marc, Nizard, Jacky, and Charron, Philippe
- Subjects
PERIPARTUM cardiomyopathy ,DISEASE risk factors ,ARRHYTHMOGENIC right ventricular dysplasia ,PREGNANCY complications ,CARDIOMYOPATHIES ,PREGNANCY - Abstract
Aims: Inherited cardiomyopathies are relatively rare but carry a high risk of cardiac maternal morbidity and mortality during pregnancy and postpartum. However, data for risk stratification are scarce. The new CARPREG II score improves prediction of prognosis in pregnancies associated with heart disease, though its role in inherited cardiomyopathies is unclear. We aim to describe characteristics and cardiac maternal outcomes in patients with inherited cardiomyopathy during pregnancy, and to evaluate the interest of the CARPREG II risk score in this population. Methods and results: In this retrospective single‐centre study, 90 consecutive pregnancies in 74 patients were included (mean age 32 ± 5 years), including 28 cases of dilated cardiomyopathy (DCM), 46 of hypertrophic cardiomyopathy, 11 of arrhythmogenic right ventricular cardiomyopathy and 5 of left ventricular noncompaction, excluding peripartum cardiomyopathy. The discriminatory power of several risk scores was assessed by the area under the receiver‐operating characteristic curve (AUC). Median CARPREG II score was 2 [0;3] and was higher in the DCM subgroup. A severe cardiac maternal complication was observed in 18 (20%) pregnancies, mainly driven by arrhythmia and heart failure (each event in 10 pregnancies), with 3 cardiovascular deaths. Forty‐three pregnancies (48%) presented foetal/neonatal complications (18 premature delivery, 3 foetal/neonatal death). CARPREG II was significantly associated with cardiac maternal complications (P < 0.05 for all) and showed a higher AUC (0.782) than CARPREG (0.755), mWHO (0.697) and ZAHARA (0.604). Conclusions: Pregnancy in women with inherited cardiomyopathy carries a high risk of maternal cardiovascular complications. CARPREG II is the most efficient predictor of cardiovascular complications in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Meeting Abstracts from the 5th National Big Data Health Science Conference.
- Subjects
- *
SCIENCE conferences , *PERIPARTUM cardiomyopathy , *PELVIC pain , *DATA science , *BIG data , *MEDICAL personnel , *HEALTH services administration - Abstract
into account when analyzing stroke-related deficits.P30: This study explores the relationship between sleep duration and cognitive function in older adults. The researchers analyzed data from the National Health and Aging Trends Study and found that both short and long sleep durations were associated with poorer cognitive function. The findings suggest that maintaining an optimal sleep duration is important for cognitive health in older adults.P31: This study investigates the impact of neighborhood characteristics on physical activity levels among older adults. The researchers used data from the Health and Retirement Study and found that neighborhood walkability, safety, and social cohesion were positively associated with physical activity. The findings highlight the importance of creating age-friendly neighborhoods that promote physical activity and support healthy aging.P32: This study examines the relationship between social media use and mental health outcomes among college students. The researchers surveyed college students and found that higher levels of social media use were associated with increased symptoms of depression and anxiety. The findings suggest that promoting healthy social media use and providing mental health support for college students is crucial.P33: This study explores the impact of mindfulness-based interventions on stress and well-being in healthcare professionals. The researchers conducted a systematic review and meta-analysis of randomized controlled trials and found that mindfulness-based interventions were effective in reducing stress and improving well-being among healthcare professionals. The findings suggest that incorporating mindfulness practices into healthcare settings can benefit both healthcare professionals and patient outcomes.P34: This study investigates the relationship between physical activity and mental health outcomes in adolescents. The researchers analyzed data from the National [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
20. Immunometric and functional measurement of endogenous vasoinhibin in human sera.
- Author
-
Zamora, Magdalena, Harris, David, Davies, Nils, Ebnet, Johannes, Radermacher, Peter, Brucker, Cosima, Waller, Christiane, Robles, Juan Pablo, Bertsch, Thomas, Clapp, Carmen, and Triebel, Jakob
- Subjects
PREECLAMPSIA ,INHIBIN ,ENZYME-linked immunosorbent assay ,HYPERTENSION in pregnancy ,CHORIOALLANTOIS ,PREGNANT women ,PERIPARTUM cardiomyopathy - Abstract
Introduction: Circulating levels of the antiangiogenic protein vasoinhibin, a fragment of prolactin, are of interest in vasoproliferative retinopathies, preeclampsia, and peripartum cardiomyopathy; however, it is difficult to determine the circulating levels of vasoinhibin due to the lack of quantitative assays. Methods: This study used human serum samples to assess the concentration and bioactivity of vasoinhibin using a novel enzyme-linked immunosorbent assay (ELISA) for human vasoinhibin, which employs an anti-vasoinhibin monoclonal antibody, a human umbilical vein endothelial cell (HUVEC) proliferation assay, and a chick chorioallantoic membrane (CAM) angiogenesis assay. Results: Serum samples from 17 pregnant women without (one group) and with preeclampsia and pregnancy induced hypertension (another group) demonstrated endogenous vasoinhibin concentrations in the range of 5-340 ng/ml. Immunoactive vasoinhibin levels were significantly higher in preeclampsia serum compared to healthy pregnancy serum (mean 63.09 ± 22.15 SD vs. 19.67 ± 13.34 ng/ml, p = 0.0003), as was the bioactive vasoinhibin level as determined by the HUVEC proliferation assay (56.12 ± 19.83 vs. 13.38 ± 4.88 ng/ml, p < 0.0001). There was a correlation between the concentration of vasoinhibin measured by ELISA and the HUVEC proliferation assay (Pearson r = 0.95, p < 0.0001). Healthy serum demonstrated a proangiogenic effect in the CAM assay (p < 0.05, compared to control), while serum from preeclamptic patients demonstrated an antiangiogenic effect (p < 0.05 vs. control), as did recombinant human vasoinhibin and a synthetic circular retro-inverse vasoinhibin analogue (CRIVi45-51). The antiangiogenic effects in the CAM assay and the inhibition of HUVEC proliferation were abolished by addition of the ELISA anti-vasoinhibin monoclonal antibody, but not by mouse IgG. Discussion: These results demonstrate the first quantitation of endogenous vasoinhibin in human sera and the elevation of it levels and antiangiogenic activity in sera from women with preeclampsia. The development and implementation of a quantitative assay for vasoinhibin overcomes a longstanding barrier and suggests the thorough clinical verification of vasoinhibin as a relevant biomarker. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Recovery of left ventricular systolic function in peripartum cardiomyopathy: an observational study from rural Tanzania.
- Author
-
Katende, Andrew, Roos, Laurine, Urio, Victor Z., Mahundi, Evance, Myovela, Victor, Mnzava, Dorcas, Mlula, Chipegwa, Chitimbwa, Christamonica, Raphael, Dominick M., Gingo, Winfrid, Franzeck, Fabian C., Paris, Daniel H., Elzi, Luigia, Weisser, Maja, and Rohacek, Martin
- Subjects
PERIPARTUM cardiomyopathy ,VENTRICULAR ejection fraction ,CARDIOVASCULAR agents ,SCIENTIFIC observation - Abstract
Background: The aim of this study was to evaluate the recovery rate of the left ventricular systolic function of women diagnosed with peripartum cardiomyopathy receiving specialized care in rural Tanzania. Methods: In this observational study, women diagnosed with peripartum cardiomyopathy at a referral center in rural Tanzania between December 2015 and September 2021 were included. Women diagnosed between February and September 2021 were followed prospectively, those diagnosed between December 2015 and January 2021 were tracked back for a follow-up echocardiography. All participants received a clinical examination, a comprehensive echocardiogram, and a prescription of guideline-directed medical therapy. The primary outcome was recovery of the left ventricular systolic function (left ventricular ejection fraction > 50%). Results: Median age of the 110 participants was 28.5 years (range 17–45). At enrolment, 49 (45%) participants were already on cardiac medication, 50 (45%) had severe eccentric hypertrophy of the left ventricle, and the median left ventricular ejection fraction was 30% (range 15–46). After a median follow-up of 8.98 months (IQR 5.72–29.37), 61 (55%) participants were still on cardiac medication. Full recovery of the left ventricular systolic function was diagnosed in 76 (69%, 95% CI 59.6–77.6%) participants. In the multivariate analysis, a higher left ventricular ejection fraction at baseline was positively associated with full recovery (each 5% increase; OR 1.7, 95% CI 1.10–2.62, p = 0.012), while higher age was inversely associated (each 10 years increase; OR 0.40, 95% CI 0.19–0.82, p = 0.012). Conclusion: Left ventricular systolic function recovered completely in 69% of study participants with peripartum cardiomyopathy from rural Tanzania under specialized care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Cardio-obstetrics: a new specialty.
- Author
-
Braunwald, Eugene
- Subjects
PERIPARTUM cardiomyopathy ,CONGENITAL heart disease ,HIGH-risk pregnancy ,PLACENTAL growth factor ,PREGNANCY outcomes ,HEART valve diseases - Abstract
The article discusses the emerging field of cardio-obstetrics, which focuses on the interactions between cardiovascular disorders (CVD) and pregnancy. It highlights the global decrease in maternal mortality rates, but notes that the mortality ratio has increased in the United States, particularly among Black women. The World Health Organization has developed a risk stratification assessment for pregnant women with CVD, and multidisciplinary teams involving cardiologists and obstetricians are recommended for the management of high-risk pregnancies. The article also discusses specific cardiovascular disorders unique to pregnancy, such as pre-eclampsia and peripartum cardiomyopathy, and emphasizes the need for further research in the field. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
23. Informing preconception counseling: Outcomes among female heart transplant recipients in the ISHLT registry.
- Author
-
Bhagra, Catriona J., Cherikh, Wida S., Ross, Heather, Kittleson, Michelle M., Stehlik, Josef, Lewis, Alexandra, DeFilippis, Ersilia M., and Macera, Francesca
- Subjects
- *
HEART transplant recipients , *KIDNEY transplantation , *CHILDBEARING age , *HEART transplantation , *LUNG transplantation , *TRANSPLANTATION of organs, tissues, etc. , *PERIPARTUM cardiomyopathy - Abstract
The numbers of women of child-bearing age undergoing heart transplantation (HT) and female pediatric HT recipients surviving to child-bearing age have increased, along with improvements in post-transplant survival. Data regarding life expectancy and comorbidities in reproductive-aged female HT recipients are needed to inform shared decision-making at the time of preconception counseling. The International Society for Heart and Lung Transplantation (ISHLT) Thoracic Organ Transplant Registry was investigated for HT recipients between January 1, 2000 and June 30, 2017. Women of childbearing age were defined as those aged 15–45 years, either at transplant, or at the respective post-transplant follow-up. Characteristics and outcomes of female recipients of childbearing age at transplant, 5-, 10-, and 15-year follow-up were compared to females > 45 years of age, males 15–45 years and males > 45 years of age at the corresponding time intervals. Outcomes included survival, development of diabetes (DM), severe renal dysfunction (CKD), and cardiac allograft vasculopathy (CAV). During the study period, 71,585 HT recipients were included: 24% (n = 17,194) were female and 9.2% (n = 6602) were of childbearing age at HT. A pre-transplant diagnosis of peripartum cardiomyopathy was associated with significantly worse post-transplant survival, a finding that remained independent of panel reactive antibody levels. The presence of pre-transplant DM and/or severe CKD was significantly associated with lower survival as were the presence of CAV, DM, and CKD post-HT. Knowledge of the impact of pre-existing comorbidities and complications post-HT on survival are important for risk stratification for preconception counseling post-HT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis.
- Author
-
Zahid, Salman, Mohamed, Mohamed S, Rajendran, Aardra, Minhas, Anum S, Khan, Muhammad Zia, Nazir, Noreen T, Ocon, Anthony J, Weber, Brittany N, Isiadinso, Ijeoma, and Michos, Erin D
- Subjects
CARDIOLOGICAL manifestations of general diseases ,GESTATIONAL diabetes ,RHEUMATOID arthritis ,PREGNANT women ,PERIPARTUM cardiomyopathy - Abstract
Background and Aims Persons with rheumatoid arthritis (RA) have an increased risk of obstetric-associated complications, as well as long-term cardiovascular (CV) risk. Hence, the aim was to evaluate the association of RA with acute CV complications during delivery admissions. Methods Data from the National Inpatient Sample (2004–2019) were queried utilizing ICD-9 or ICD-10 codes to identify delivery hospitalizations and a diagnosis of RA. Results A total of 12 789 722 delivery hospitalizations were identified, of which 0.1% were among persons with RA (n = 11 979). Individuals with RA, vs. those without, were older (median 31 vs. 28 years, P <.01) and had a higher prevalence of chronic hypertension, chronic diabetes, gestational diabetes mellitus, obesity, and dyslipidaemia (P <.01). After adjustment for age, race/ethnicity, comorbidities, insurance, and income, RA remained an independent risk factor for peripartum CV complications including preeclampsia [adjusted odds ratio (aOR) 1.37 (95% confidence interval 1.27–1.47)], peripartum cardiomyopathy [aOR 2.10 (1.11–3.99)], and arrhythmias [aOR 2.00 (1.68–2.38)] compared with no RA. Likewise, the risk of acute kidney injury and venous thromboembolism was higher with RA. An overall increasing trend of obesity, gestational diabetes mellitus, and acute CV complications was also observed among individuals with RA from 2004–2019. For resource utilization, length of stay and cost of hospitalization were higher for deliveries among persons with RA. Conclusions Pregnant persons with RA had higher risk of preeclampsia, peripartum cardiomyopathy, arrhythmias, acute kidney injury, and venous thromboembolism during delivery hospitalizations. Furthermore, cardiometabolic risk factors among pregnant individuals with RA rose over this 15-year period. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Disease features and management of cardiomyopathies in women.
- Author
-
Aimo, Alberto, Morfino, Paolo, Arzilli, Chiara, Vergaro, Giuseppe, Spini, Valentina, Fabiani, Iacopo, Castiglione, Vincenzo, Rapezzi, Claudio, and Emdin, Michele
- Subjects
PERIPARTUM cardiomyopathy ,DISEASE management ,WOMEN executives ,HYPERTROPHIC cardiomyopathy ,MITOCHONDRIAL pathology ,SYMPTOMS - Abstract
Over the last years, there has been a growing interest in the clinical manifestations and outcomes of cardiomyopathies in women. Peripartum cardiomyopathy is the only women-specific cardiomyopathy. In cardiomyopathies with X-linked transmission, women are not simply healthy carriers of the disorder, but can show a wide spectrum of clinical manifestations ranging from mild to severe manifestations because of heterogeneous patterns of X-chromosome inactivation. In mitochondrial disorders with a matrilinear transmission, cardiomyopathy is part of a systemic disorder affecting both men and women. Even some inherited cardiomyopathies with autosomal transmission display phenotypic and prognostic differences between men and women. Notably, female hormones seem to exert a protective role in hypertrophic cardiomyopathy (HCM) and variant transthyretin amyloidosis until the menopausal period. Women with cardiomyopathies holding high-risk features should be referred to a third-level center and evaluated on an individual basis. Cardiomyopathies can have a detrimental impact on pregnancy and childbirth because of the associated hemodynamic derangements. Genetic counselling and a tailored cardiological evaluation are essential to evaluate the likelihood of transmitting the disease to the children and the possibility of a prenatal or early post-natal diagnosis, as well as to estimate the risk associated with pregnancy and delivery, and the optimal management strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers.
- Author
-
Trimarchi, Giancarlo, Teresi, Lucio, Licordari, Roberto, Pingitore, Alessandro, Pizzino, Fausto, Grimaldi, Patrizia, Calabrò, Danila, Liotta, Paolo, Micari, Antonio, de Gregorio, Cesare, and Di Bella, Gianluca
- Subjects
LEFT ventricular dysfunction ,CARDIOMYOPATHIES ,TAKOTSUBO cardiomyopathy ,SPONTANEOUS coronary artery dissection ,CENTRAL nervous system injuries ,MUCOCUTANEOUS lymph node syndrome ,PERIPARTUM cardiomyopathy - Abstract
Transient left ventricular dysfunction (TLVD), a temporary condition marked by reversible impairment of ventricular function, remains an underdiagnosed yet significant contributor to morbidity and mortality in clinical practice. Unlike the well-explored atherosclerotic disease of the epicardial coronary arteries, the diverse etiologies of TLVD require greater attention for proper diagnosis and management. The spectrum of disorders associated with TLVD includes stress-induced cardiomyopathy, central nervous system injuries, histaminergic syndromes, various inflammatory diseases, pregnancy-related conditions, and genetically determined syndromes. Furthermore, myocardial infarction with non-obstructive coronary arteries (MINOCA) origins such as coronary artery spasm, coronary thromboembolism, and spontaneous coronary artery dissection (SCAD) may also manifest as TLVD, eventually showing recovery. This review highlights the range of ischemic and non-ischemic clinical situations that lead to TLVD, gathering conditions like Tako-Tsubo Syndrome (TTS), Kounis syndrome (KS), Myocarditis, Peripartum Cardiomyopathy (PPCM), and Tachycardia-induced cardiomyopathy (TIC). Differentiation amongst these causes is crucial, as they involve distinct clinical, instrumental, and genetic predictors that bode different outcomes and recovery potential for left ventricular function. The purpose of this review is to improve everyday clinical approaches to treating these diseases by providing an extensive survey of conditions linked with TLVD and the elements impacting prognosis and outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
- Author
-
Jackson, Alice M, Goland, Sorel, Farhan, Hasan Ali, Yaseen, Israa Fadhil, Prameswari, Hawani Sasmaya, Böhm, Michael, Jhund, Pardeep S, Maggioni, Aldo P, van der Meer, Peter, Sliwa, Karen, Bauersachs, Johann, and Petrie, Mark C
- Subjects
PERIPARTUM cardiomyopathy ,ECLAMPSIA ,HUMAN Development Index ,PROGNOSTIC models ,HEART failure ,SYMPTOMS - Abstract
Background and Aims There are no established clinical tools to predict left ventricular (LV) recovery in women with peripartum cardiomyopathy (PPCM). Using data from women enrolled in the ESC EORP PPCM Registry, the aim was to derive a prognostic model to predict LV recovery at 6 months and develop the 'ESC EORP PPCM Recovery Score'—a tool for clinicians to estimate the probability of LV recovery. Methods From 2012 to 2018, 752 women from 51 countries were enrolled. Eligibility included (i) a peripartum state, (ii) signs or symptoms of heart failure, (iii) LV ejection fraction (LVEF) ≤ 45%, and (iv) exclusion of alternative causes of heart failure. The model was derived using data from participants in the Registry and internally validated using bootstrap methods. The outcome was LV recovery (LVEF ≥50%) at six months. An integer score was created. Results Overall, 465 women had a 6-month echocardiogram. LV recovery occurred in 216 (46.5%). The final model included baseline LVEF, baseline LV end diastolic diameter, human development index (a summary measure of a country's social and economic development), duration of symptoms, QRS duration and pre-eclampsia. The model was well-calibrated and had good discriminatory ability (C -statistic 0.79, 95% confidence interval [CI] 0.74–0.83). The model was internally validated (optimism-corrected C -statistic 0.78, 95% CI 0.73–0.82). Conclusions A model which accurately predicts LV recovery at 6 months in women with PPCM was derived. The corresponding ESC EORP PPCM Recovery Score can be easily applied in clinical practice to predict the probability of LV recovery for an individual in order to guide tailored counselling and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Diagnosis and management of peripartum cardiomyopathy and recurrence risk
- Author
-
Giulia Iannaccone, Francesca Graziani, Polona Kacar, Pietro Paolo Tamborrino, Rosa Lillo, Claudia Montanaro, Francesco Burzotta, and Michael A. Gatzoulis
- Subjects
Peripartum cardiomyopathy ,Pregnancy ,Cardiovascular disease ,Subsequent pregnancy ,Pathophysiology ,Prognosis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Peripartum cardiomyopathy (PPCM) is a rare, but serious condition, with a non-negligible risk of adverse events. Several risk factors for PPCM have been individuated over the years, including Afro-American ethnicity, preeclampsia, advanced maternal age, genetic predisposition, multiparity, twin pregnancy, obesity, smoking and diabetes. However, PPCM pathophysiology is still poorly understood, thus making it challenging to develop disease specific therapies. At present, Bromocriptine is the only targeted drug, but further evidence is needed to establish indication and timing of administration. Therefore, these patients are mainly treated following general heart failure guidelines. Even though in most patients left ventricular ejection fraction recovers during follow-up, cases of persistent left ventricular dysfunction are not uncommon. Moreover, all patients detain a certain risk of recurrence after subsequent pregnancies, which is difficult to estimate due to the dearth of long-term prospective data.In this manuscript, we aim to provide an updated review of current evidence about PPCM pathophysiology, diagnosis, treatment and recurrence risk. In addition, we discuss the gaps in knowledge that should be addressed by future research.
- Published
- 2024
- Full Text
- View/download PDF
29. Temporal Trends in Clinical Characteristics and Outcomes for Peripartum Cardiomyopathy: The Nationwide Multicenter Registry Over 20 Years
- Author
-
Minjung Bak, Jong‐Chan Youn, Dae‐Hwan Bae, Ju‐Hee Lee, Sunki Lee, Dong‐Hyuk Cho, and Jin‐Oh Choi
- Subjects
body mass index ,gestational diabetes ,left ventricular end‐diastolic dimension ,death ,peripartum cardiomyopathy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Although peripartum cardiomyopathy (PPCM) is a fatal disease affecting young patients and fetuses, little is known about its recent prognosis and risk factors. This study investigated temporal trends in clinical characteristics and outcomes for PPCM in a nationwide multicenter registry. Methods and Results The study population comprised 340 patients (mean age, 33 years) who were diagnosed with PPCM between January 2000 and September 2022 in 26 tertiary hospitals in South Korea. PPCM was defined as heart failure with left ventricular ejection fraction ≤45% and no previously known cardiac disease. The main study outcomes included time to the first occurrence of all‐cause death, heart transplantation, and cardiovascular hospitalization. The diagnosis of PPCM cases increased notably during the study period (P
- Published
- 2024
- Full Text
- View/download PDF
30. Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
- Author
-
Adedinsewo, Demilade
- Subjects
- *
PERIPARTUM cardiomyopathy , *ARTIFICIAL intelligence , *HEALTH equity - Abstract
The article discusses the potential of artificial intelligence (AI) to improve cardiovascular health equity. It highlights the impact of technology on our lives and the advancements in AI in the field of cardiovascular medicine. The article also acknowledges the disproportionate effect of cardiovascular disease on racial and ethnic minority individuals in the United States and emphasizes the importance of addressing health disparities. It discusses the concept of algorithmic bias and the ethical considerations that should be taken into account when implementing AI interventions. The article concludes by emphasizing the ethical responsibility to adopt low-risk, high-reward AI technologies that benefit all patients and contribute to health equity. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
31. Navigating between Scylla and Charybdis: Diuretics during pregnancy – as much as needed, but the least possible.
- Author
-
Bauersachs, Johann and Berliner, Dominik
- Subjects
- *
HEART failure , *PERIPARTUM cardiomyopathy , *DIURETICS , *PREGNANCY , *HEART valve diseases - Abstract
The article discusses the use of diuretics during pregnancy for women with heart failure and/or congenital heart and/or valvular heart disease. The care of these patients during pregnancy is largely based on expert opinion rather than evidence-based studies. The article presents data from the ESC Registry of Pregnancy and Cardiac Disease, showing that diuretics can be used during pregnancy when clearly indicated based on the mother's disease. The data mainly refer to the loop diuretic furosemide, and other diuretic medications were used less frequently. The article emphasizes the need for an individualized patient-centered approach and collaboration between cardiologists and obstetricians in the care of pregnant women with cardiac diseases. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
32. A rare case with double trouble: Peripartum cardiomyopathy and preeclampsia together with placental abruption resulting in both cardiac and kidney failure.
- Author
-
Kumari, Anupma, Prasad, Indira, Sahay, Nishant, Kumar, Rajnish, and Agrawal, Mukta
- Subjects
- *
ABORTION , *ACUTE kidney failure , *POSTOPERATIVE period , *HEART failure , *KIDNEY failure , *PERIPARTUM cardiomyopathy , *ABRUPTIO placentae - Abstract
Peripartum cardiomyopathy and hypertensive disorders of pregnancy are not very uncommon in routine practice, but when associated with abruptio placentae and significant hypotension, survival of both child and mother becomes challenging. We report a case of a 20-year-old primigravida who presented in the gynecology emergency unit of our hospital with an ejection fraction of < 20%, severe preeclampsia with abruptio placentae leading to fetal demise, and renal failure in the immediate postoperative period. Challenges faced during decision making regarding the mode of delivery and grave concerns during intraoperative and postoperative periods are discussed. In this case, prompt termination of pregnancy, various point-of-care sonographic measurements, and post-operative emergency dialysis played vital roles in the complete recovery of this patient with a failing heart and grossly jeopardized hemodynamics. Hence, multidisciplinary team-based management is crucial for managing such cases to prevent maternal mortality and morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. A rare case with double trouble: Peripartum cardiomyopathy and preeclampsia together with placental abruption resulting in both cardiac and kidney failure
- Author
-
Anupma Kumari, Indira Prasad, Nishant Sahay, Rajnish Kumar, and Mukta Agrawal
- Subjects
acute kidney failure ,peripartum cardiomyopathy ,placental abruption ,primigravida ,Medicine - Abstract
Peripartum cardiomyopathy and hypertensive disorders of pregnancy are not very uncommon in routine practice, but when associated with abruptio placentae and significant hypotension, survival of both child and mother becomes challenging. We report a case of a 20-year-old primigravida who presented in the gynecology emergency unit of our hospital with an ejection fraction of < 20%, severe preeclampsia with abruptio placentae leading to fetal demise, and renal failure in the immediate postoperative period. Challenges faced during decision making regarding the mode of delivery and grave concerns during intraoperative and postoperative periods are discussed. In this case, prompt termination of pregnancy, various point-of-care sonographic measurements, and post-operative emergency dialysis played vital roles in the complete recovery of this patient with a failing heart and grossly jeopardized hemodynamics. Hence, multidisciplinary team-based management is crucial for managing such cases to prevent maternal mortality and morbidity.
- Published
- 2024
- Full Text
- View/download PDF
34. Paro cardiorrespiratorio secundario a miocardiopatía periparto: reporte de un caso
- Author
-
Jorge Rodríguez Zúñiga, Karen Elena Ortega Verdugo, and Diego Ernesto Pacheco Zavala
- Subjects
Peripartum Cardiomyopathy ,Heart Failure ,Cardiogenic Shock ,Heart Arrest ,Puerperium ,Pregnancy ,Medicine - Abstract
Resumen: Objetivo: Reportar un caso de miocardiopatía periparto, con presentación de choque cardiogénico y paro cardiorrespiratorio, que presentó una evolución adecuada con secuelas mínimas. Caso clínico: Paciente femenina de 31 años de edad, con embarazo a término, sin comorbilidades. Se realiza cesárea programada por doble circular de cordón. Durante el procedimiento la paciente presenta paro cardiorrespiratorio, con retorno a la circulación espontánea. Posteriormente, evoluciona con choque cardiogénico, arritmias y complicaciones tromboembólicas, requiriendo manejo en la unidad de cuidados intensivos. Presenta evolución clínica favorable, logrando retiro de las medidas de soporte, continuando con manejo ambulatorio de sus complicaciones.La miocardiopatía periparto sigue siendo una patología de presentación infrecuente, requiriendo una alta sospecha para llegar a un diagnóstico temprano y abordaje oportuno. El uso de herramientas como la ecocardiografía son imprescindibles en la evaluación inicial. Esta enfermedad requiere de un manejo multidisciplinario en un centro especializado. Abstract: Objective: To report a case of peripartum cardiomyopathy with cardiogenic shock and cardiorespiratory arrest, which presented an adequate response to treatment with minimal sequelae. Clinical case: 31-year-old female, with a full-term pregnancy, without comorbidities. A scheduled cesarean section was performed due to a double circular cord. During the procedure, the patient presented cardiorespiratory arrest with return to spontaneous circulation. The patient later presents cardiogenic shock, arrhythmias and thromboembolic events, requiring management in the intensive care unit. The patient had a favorable clinical evolution, allowing for withdrawal of support measures and outpatient management of minor complications.Peripartum cardiomyopathy is a pathology with an infrequent presentation. In order to be addressed in a timely manner, high suspicion is required to reach an early diagnosis. The use of implements such as echocardiography is essential in the initial evaluation. Multidisciplinary management in a specialized center is required.
- Published
- 2024
- Full Text
- View/download PDF
35. Clinical Presentation and 6-Month Outcomes of Patients with Peripartum Cardiomyopathy in Indonesia
- Author
-
Prameswari HS, Dewi TI, Hasan M, Martanto E, Astuti A, Saboe A, and Cool CJ
- Subjects
peripartum cardiomyopathy ,preeclampsia ,ppcm ,recovery ,registry ,Medicine (General) ,R5-920 - Abstract
Hawani Sasmaya Prameswari, Triwedya Indra Dewi, Melawati Hasan, Erwan Martanto ,† Astri Astuti, Aninka Saboe, Charlotte Johanna Cool Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia†Erwan Martanto passed away on 17 August 2023Correspondence: Hawani Sasmaya Prameswari, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Email hawanisasmaya@gmail.comBackground: Due to the rarity of peripartum cardiomyopathy (PPCM) globally, baseline characteristic data for PPCM patients are still scarce. Therefore, this study aims to determine the baseline characteristics and 6-month outcomes of PPCM patients in Indonesia.Methods: From January 2014 to December 2021, all PPCM patients aged ≥ 18 years who were admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia, participated in this single-center, prospective cohort study. All patients were re-evaluated within 6 months of PPCM diagnosis.Results: A total of 138 patients with PPCM were admitted to Dr. Hasan Sadikin General Hospital in Bandung. The mean age of all patients was 30.4 ± 6.4 years old. Approximately 60% patients were multipara and had preeclampsia. All guideline-directed medical therapy for heart failure was received by most patients, excluding mineralocorticoid receptor antagonists (25.2%) and bromocriptine (14.1%). The neonatal mortality rate was 5.1%. Among those who survived, 61.2% had normal weight, 31.8% had low birth weight, and 7% had very low birth weight. At the 6-month follow-up, 6.7% of the patients died, 63.3% recovered, and 1.9% were rehospitalized.Conclusion: The present study found a high incidence of PPCM in Indonesia. Our patients frequently had preeclampsia, which contributed to the higher rate of miscarriage and low birth weight. Our liberal use of beta-blockers and ACEi/ARB may have contributed to the higher 6-month recovery rate than that in other countries.Keywords: peripartum cardiomyopathy, preeclampsia, PPCM, recovery, registry
- Published
- 2024
36. Guyton perspective in managing peripartum cardiomyopathy patient with pulmonary edema: a case report
- Author
-
Ruth Evlin Margaretha, Yohanes W. H. George, and Jefferson Hidayat
- Subjects
Peripartum cardiomyopathy ,Furosemide ,Negative cumulative fluid balance ,Oxygenation improvement ,Case report ,Medicine - Abstract
Abstract Background Peripartum cardiomyopathy (PPCM) is a potentially life-threatening pregnancy-related condition characterized by left ventricular dysfunction and heart failure, typically occurring in the peripartum period. Individuals with a history of preeclampsia and hypertension are particularly prone to developing PPCM. Recent research suggests that the condition may be triggered by vascular dysfunction influenced by maternal hormones in the late stages of gestation. The onset of left heart failure results in decreased cardiac output, leading to insufficient perfusion, which in turn, contributes to pulmonary edema and exacerbates tissue hypoxia. This cardiovascular response activates the neurohumoral system, causing peripheral vasoconstriction and elevating both mean capillary filling pressure (MCFP) and central venous pressure (CVP). Early administration of furosemide reduces volume overload due to negative cumulative fluid balance gaining and vasodilation, which increases the velocity of intravascular refilling and causes interstitial edema to resolve. This will decrease interstitial fluid pressure, resulting in decreased mechanical compression to systemic capillary and systemic vein pressure, thus decreasing MCFP and CVP subsequently. Reduced CVP also contributes to increased venous return by decreasing the gradient pressure between MCFP and CVP, resulting in increased cardiac output (CO) and improved tissue oxygenation. Case A 33-year-old Asian woman, para 3 at full term pregnancy, admitted to the intensive care unit (ICU) after c-section and tubectomy due to shortness of breath and palpitation. Based on history taking, physical examination and echocardiography the patient fulfilled the criteria of PPCM which was also complicated by pulmonary edema. Despite impending respiratory failure, the patient rejected intubation and continuous positive airway pressure (CPAP), and was given oxygen supplementation through nasal cannula. Furosemide was given rapidly continued by maintenance dose and CVP was monitored. Antihypertensive drug, anticoagulants, and bromocriptine were also administered. After achieving negative cumulative fluid balance the patient’s symptoms resolved and was discharged one week later. Conclusion There is a correlation between negative cumulative fluid balance and reduced central venous pressure after early furosemide therapy. Suspicion for PPCM should not be lowered in the presence of preeclampsia, it could delay appropriate treatment and increase the mortality.
- Published
- 2024
- Full Text
- View/download PDF
37. Contemporary Management of Cardiomyopathy and Heart Failure in Pregnancy
- Author
-
Henrietta Afari, Megan Sheehan, and Nosheen Reza
- Subjects
Pregnancy ,Heart failure ,Cardiomyopathy ,Cardio-obstetrics ,Peripartum cardiomyopathy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Cardiovascular disease is the primary cause of pregnancy-related mortality and morbidity in the United States, and maternal mortality has increased over the last decade. Pregnancy and the postpartum period are associated with significant vascular, metabolic, and physiologic adaptations that can unmask new heart failure or exacerbate heart failure symptoms in women with known underlying cardiomyopathy. There are unique management considerations for heart failure in women throughout pregnancy, and it is imperative that clinicians caring for pregnant women understand these important principles. Early involvement of multidisciplinary cardio-obstetrics teams is key to optimizing maternal and fetal outcomes. In this review, we discuss the unique challenges and opportunities in the diagnosis of heart failure in pregnancy, management principles along the continuum of pregnancy, and the safety of heart failure therapies during and after pregnancy.
- Published
- 2024
- Full Text
- View/download PDF
38. Clinical predictors of right ventricular dysfunction and association with adverse outcomes in peripartum cardiomyopathy
- Author
-
Tasnim F. Imran, Feven Ataklte, Mahnoor Khalid, Diana Lopez, Donya Mohebali, Natalie A. Bello, J. Michael Gaziano, Luc Djousse, Zolt Arany, Marwa A. Sabe, Katharine French, Athena Poppas, Wen‐Chih Wu, and Gaurav Choudhary
- Subjects
Peripartum cardiomyopathy ,Right ventricular dysfunction ,Pulmonary hypertension ,Adverse outcomes ,Pregnancy‐associated heart failure ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims We sought to identify factors associated with right ventricular (RV) dysfunction and elevated pulmonary artery systolic pressure (PASP) and association with adverse outcomes in peripartum cardiomyopathy (PPCM). Methods and results We conducted a multi‐centre cohort study to identify subjects with PPCM with the following criteria: left ventricular ejection fraction (LVEF)
- Published
- 2024
- Full Text
- View/download PDF
39. FDNC5 Genetic Polymorphism in Patients with Peripartum Cardiomyopathy
- Author
-
Ali Altaher, Mohamed eid, Hesham moslem, Amal Ali, Samar Mustafa, and Amera morad
- Subjects
fdnc5 polymorphism ,peripartum cardiomyopathy ,irisin ,Internal medicine ,RC31-1245 - Abstract
Background: Late in pregnancy or soon after delivery, peripartum cardiomyopathy (PPCM) which is an uncommon type of cardiomyopathy, can develop. To assess the association between the level of irisin expression and (FNDC5) (rs3480) gene polymorphism with peripartum cardiomyopathy. Methods: This is a case control study included a thirty female patients with new-onset PPCM and sixty healthy females at the at the peripartum period in same time window for PPCM as a control. For each patient, comprehensive medical history was taken, full clinical assessment was done, ECHO., FNDC5 (rs3480) & Irisin assay. Results: The left ventricle end diastolic dimensions &left atrium diameters were statistically significant higher in patients’ group than controls’ group (P=0.000 for all), Also left ventricular ejection fraction (%) was statistically significant lower in patients than controls and as regards irisin, its Mean ±SD was lower in patient group than control group (8.44±1.1 vs 10.65±2.31) with (p
- Published
- 2024
40. Bromocriptine in the Treatment of Peripartum Cardiomyopathy (BRO-HF)
- Author
-
Canadian Cardiovascular Society and Marc Jolicoeur, Lead investigator
- Published
- 2023
41. Temporary mechanical circulatory support as a bridge to transplant in peripartum cardiomyopathy
- Author
-
Cindy Song, BA, Spencer Kim, BA, Amit Iyengar, MD, MSE, David Rekhtman, BS, Noah Weingarten, MD, Max Shin, MD, Joyce Jiang, BS, Michaela Asher, MPhil, Marisa Cevasco, MD, MPH, and Pavan Atluri, MD
- Subjects
temporary mechanical circulatory support ,peripartum cardiomyopathy ,intra-aortic balloon pump ,heart failure ,heart transplant ,Surgery ,RD1-811 ,Specialties of internal medicine ,RC581-951 - Abstract
Background: Use of temporary mechanical circulatory support (tMCS) for peripartum cardiomyopathy (PPCM) shock has been described in small cohorts, but not on a national scale. This study compares tMCS, durable MCS (dMCS), and no MCS as bridge to transplant strategies for PPCM. Methods: Female patients ≥14 years, listed for first-time isolated heart transplant (HT) between January 1, 2000 and June 30, 2021, were identified in the United Network for Organ Sharing database. Patients were stratified by receipt of MCS at any point during the waitlist period. Patients on multiple devices were excluded. Results: A total of 1,043 PPCM patients were listed for HT, including 575 bridged on no MCS, 177 on tMCS, and 291 on dMCS. The tMCS cohort included 10 patients on extracorporeal membrane oxygenation, 113 on intra-aortic balloon pump, and 54 on nondischargeable ventricular assist device (VAD) or percutaneous device. The dMCS group primarily received durable VADs. Compared to dMCS, tMCS recipients were more likely to require inotropes, mechanical ventilation, and longer hospitalizations pretransplant (all p 0.05). After multivariable risk adjustment, neither tMCS (adjusted hazard ratio 0.56 [0.06-5.43]) nor dMCS (adjusted hazard ratio 0.36 [0.05-2.82]) significantly predicted 3-year graft survival. Conclusions: Compared to patients bridged to HT on dMCS or no MCS, PPCM patients receiving tMCS are higher acuity candidates but have equivalent post-transplant graft survival.
- Published
- 2024
- Full Text
- View/download PDF
42. Contemporary Management of Cardiomyopathy and Heart Failure in Pregnancy.
- Author
-
Afari, Henrietta, Sheehan, Megan, and Reza, Nosheen
- Subjects
- *
PERIPARTUM cardiomyopathy , *HEART failure , *CARDIOMYOPATHIES , *PREGNANCY , *PREGNANT women , *MATERNAL mortality , *CARDIOVASCULAR diseases - Abstract
Cardiovascular disease is the primary cause of pregnancy-related mortality and morbidity in the United States, and maternal mortality has increased over the last decade. Pregnancy and the postpartum period are associated with significant vascular, metabolic, and physiologic adaptations that can unmask new heart failure or exacerbate heart failure symptoms in women with known underlying cardiomyopathy. There are unique management considerations for heart failure in women throughout pregnancy, and it is imperative that clinicians caring for pregnant women understand these important principles. Early involvement of multidisciplinary cardio-obstetrics teams is key to optimizing maternal and fetal outcomes. In this review, we discuss the unique challenges and opportunities in the diagnosis of heart failure in pregnancy, management principles along the continuum of pregnancy, and the safety of heart failure therapies during and after pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Apoptosis, a useful marker in the management of hot‐phase cardiomyopathy?
- Author
-
Bassetto, Giulia, Merlo, Marco, Dal Ferro, Matteo, Setti, Martina, Paldino, Alessia, Collesi, Chiara, Artioli, Rebecca, Loffredo, Francesco, D'Elia, Saverio, Golino, Paolo, Fabris, Enrico, Bussani, Rossana, Metra, Marco, Limongelli, Giuseppe, and Sinagra, Gianfranco
- Subjects
- *
ARRHYTHMOGENIC right ventricular dysplasia , *APOPTOSIS , *CARDIOMYOPATHIES , *PERIPARTUM cardiomyopathy , *VENTRICULAR ejection fraction , *GENETIC testing , *SYMPTOMS - Abstract
Aims: 'Hot phases', characterized by chest pain and troponin release, may represent the first clinical presentation of arrhythmogenic cardiomyopathies. Differential diagnosis with acute myocarditis is an unmet challenge for the clinicians. We sought to investigate histological and genetic features in patients with cardiomyopathy presenting with hot phases. Methods and results: We evaluated a case series of consecutive patients hospitalized for suspected 'hot‐phase cardiomyopathy' in two Italian centres from June 2017 to March 2022 (median follow‐up 18 months) that underwent both endomyocardial biopsy (EMB) and genetic testing. Apoptosis was confirmed with TUNEL assay. Among the 17 enrolled patients (mean age 34 ± 15 years, 76% male), only six patients (35%) presented standard histological and immunohistochemical markers for significant cardiac inflammation at EMB. Conversely, apoptosis was found in 13 patients (77%). Genetic testing was positive for a pathogenic/likely pathogenic (P/LP) variant in genes involved in cardiomyopathies (most frequently in DSP) in eight patients (48%), rising to 62% among patients with apoptosis on EMB. Notably, all patients without apoptosis tested negative for P/LP disease‐related variants. Left ventricular ejection fraction was lower in patients showing apoptosis at EMB compared to those without (p = 0.003). Conclusions: Apoptosis, rather than significant inflammation, was mostly prevalent in this case series of patients with 'hot‐phase' presentation, especially in carriers of variants in cardiomyopathy‐related genes. Detecting apoptosis on EMB might guide clinicians in performing genetic testing and in more tailored therapeutic choices in 'hot‐phase cardiomyopathy'. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Cardiomyopathy discovered during pregnancy: Insights from speckle tracking echocardiography in a cohort of pregnant patients.
- Author
-
Bahrami, Parvin, Soleimani, Azam, Zavar, Reihane, Masoumi, Hosein, and Adelparvar, Farzad
- Subjects
- *
SPECKLE tracking echocardiography , *GLOBAL longitudinal strain , *ECHOCARDIOGRAPHY , *PREGNANT women , *LEFT ventricular dysfunction , *PERIPARTUM cardiomyopathy , *HEART failure - Abstract
BACKGROUND: Heart failure (HF) is considered the leading cause of cardiac-related morbidity and mortality during pregnancy. Peripartum cardiomyopathy (PPCM) presents diagnostic challenges, often mirroring dilated cardiomyopathy (DCM). The aim of the study is to evaluate echocardiographic features, including global and segmental longitudinal strain values, in pregnant women with a history of newly diagnosed left ventricular systolic dysfunction (LVSD) in the third trimester of pregnancy. METHODS: This cross-sectional study, conducted in two referral cardio-obstetric clinics in Isfahan, Iran, enrolled pregnant women with newly diagnosed LV systolic dysfunction in the third trimester of pregnancy. A multidisciplinary pregnancy heart team assessed the patients. Reevaluation of patients and advanced echocardiographic investigation, including speckle tracking echocardiography (STE), were performed at least six months after delivery. RESULTS: The study included 26 pregnant women. Baseline characteristics revealed varying NYHA functional classes and etiologies, including DCM or non-dilated LV cardiomyopathy and PPCM. Undiagnosed DCM with exacerbation during pregnancy or non-dilated LV cardiomyopathy were the most probable causes for LV systolic dysfunction (65.4%). In five cases, peripartum cardiomyopathy was more relevant. The mean global longitudinal strain (GLS) was -16.94% and -13.95% in PPCM and DCM, respectively. Significantly different regional longitudinal strain numbers among different LV segments in PPCM were observed (P=.042), whereas the segmental strain in DCM patients did not differ. CONCLUSION: When LVSD is discovered late in pregnancy, it is not easy for the authors to differentiate between peripartum cardiomyopathy and other cardiomyopathies. Advanced echocardiographic techniques, particularly GLS analysis, may be valuable in differentiating between these conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Hypertensive Disorders of Pregnancy.
- Author
-
NEWMAN, COURTNEY, PETRUZZI, VICTORIA, RAMIREZ, PEDRO T., and HOBDAY, CHRISTOPHER
- Subjects
- *
HYPERTENSION in pregnancy , *SYSTOLIC blood pressure , *DIASTOLIC blood pressure , *BLOOD pressure , *THERAPEUTICS , *HYPERTENSIVE crisis , *PERIPARTUM cardiomyopathy - Abstract
According to the American College of Obstetricians and Gynecologists (ACOG), women who have a systolic blood pressure ≥ 140 mm Hg and/or a diastolic pressure ≥ 90 mm Hg before pregnancy or before 20 weeks of gestation have chronic hypertension. Up to 1.5% of women in their childbearing years have a diagnosis of chronic hypertension, and 16% of pregnant women develop hypertension during their pregnancy. Physiological cardiovascular changes from pregnancy may mask or exacerbate hypertensive diseases during gestation, which is why prepregnancy counseling is emphasized for all patients to optimize comorbidities and establish a patient's baseline blood pressure. This review provides an overview of the diagnoses and treatments of hypertensive diseases that can occur in pregnancy, including definitions of key terms and types of hypertension as well as ACOG recommendations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Etiology of intracerebral hemorrhage during pregnancy or puerperium: A nationwide study.
- Author
-
Vest, Teresa, Rantanen, Kirsi, Verho, Liisa, Aarnio, Karoliina, Korhonen, Aino, Richardt, Anna, Strbian, Daniel, Gissler, Mika, Laivuori, Hannele, Tikkanen, Minna, and Ijäs, Petra
- Subjects
- *
CEREBRAL hemorrhage , *PUERPERIUM , *PREGNANCY , *PREGNANCY complications , *PERIPARTUM cardiomyopathy , *ECLAMPSIA , *ETIOLOGY of diseases - Abstract
Background and purpose: Intracerebral hemorrhage during pregnancy or puerperium (pICH) is one of the leading causes of maternal death worldwide. However, limited epidemiological data exist on the etiology and outcomes of pICH, which is required to guide prevention and treatment. Methods: A retrospective nationwide cohort study and a nested case–control study was performed in Finland 1987–2016. We identified women with incident pICH by linking the Medical Birth Register (MBR) and the Hospital Discharge Register (HDR). The clinical details were collected from patient records. Three matched controls with a pregnancy without ICH were selected for each case from the MBR. Results: In total, 49 pICH cases were identified. Half of these cases occurred during pregnancy, and the other half during peripartum and puerperium. Based on the SMASH‐U (structural vascular lesion, medication, amyloid angiopathy, systemic disease, hypertension, undetermined) classification, 35.4% of the patients had a systemic disease, most commonly preeclampsia, eclampsia, or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome; 31.3% had a structural vascular lesion; 31.3% had an undetermined etiology; and one patient (2.1%) had hypertension. The most important risk factor was hypertensive disorders of pregnancy (HDP; odds ratio = 3.83, 95% confidence interval = 1.60–9.15), occurring in 31% of the cases. Maternal mortality was 12.5%, and 20.9% of the surviving women had significant disability (modified Rankin Scale = 3–5) 3 months after the pICH. Women with systemic disease had the worst outcomes. Conclusions: Even in a country with a comprehensive pregnancy surveillance system, the maternal mortality rate for pICH is high, and the sequelae are severe. Early recognition and treatment of the key risk factor, HDP, is crucial to help prevent this serious pregnancy complication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Principales características clínicas y epidemiológicas de pacientes con miocardiopatía periparto.
- Author
-
González Duany, Dioneisis Adela, Varela García, Raúl Joaquín, and Varela Garcia, Irma Dariannis
- Subjects
- *
SYMPTOMS , *HEART failure , *CARDIOVASCULAR diseases , *PERINATAL period , *VENTRICULAR ejection fraction , *PERIPARTUM cardiomyopathy - Abstract
Introduction: Cardiovascular diseases represent an important cause of morbidity and mortality during pregnancy, cardiomyopathy is notable as a syndrome of heart failure. Objective: To characterize patients with peripartum cardiomyopathy according to clinical and epidemiological variables of interest for the investigation. Methods: A descriptive and cross-sectional study of 18 patients with diagnosis of peripartum cardiomyopathy was carried out. They were assisted at Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba from October, 2015 to December, 2022. Results: In the series there was a prevalence of patients over 35 years (32.6 average age), besides African descendant (50.0 %), chronic hypertension (44.4 %) and multiparity (8.9 %) as risk factors and the left ventricle failure as clinical manifestation. The ejection fraction of this ventricle was regularly diminished and the pharmacological treatment response was satisfactory in all the sample. Conclusions: Peripartum cardiomyopathy is of low incidence in this center; however, due to its seriousness, the early diagnosis and the specialized staff intervention are necessary to avoid complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
48. Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports.
- Author
-
Takanaka, Haruka, Ono, Ryohei, Kato, Hirotoshi, Iwahana, Togo, Miyahara, Tomoki, Takahashi, Hidehisa, Hori, Yasuhiko, Fukushima, Kenichi, and Kobayashi, Yoshio
- Abstract
Peripartum cardiomyopathy (PPCM) is a rare disorder in which left ventricular systolic dysfunction and heart failure symptoms occur during the peripartum period. Inhibition of prolactin secretion by bromocriptine mediates beneficial effects on cardiac function in PPCM. Mental disorders are also associated with the onset of PPCM. Psychiatric medications for mental disorders would affect serotonin production and tryptophan and dopamine metabolism, and they are associated with PPCM. Conversely, bromocriptine affects psychiatric symptoms; therefore, the treatment of PPCM complicated by mental disorders using bromocriptine may be difficult. Herein, we report cases of two patients with PPCM and mental disorders successfully treated with bromocriptine therapy. The first case involved a 33-year-old woman with a history of atypical depression and anxiety disorder, who developed PPCM with a left ventricular ejection fraction (LVEF) of 19 %. The second case was that of a 42-year-old woman with a history of bipolar and panic disorders who developed PPCM with an LVEF of 18 %. Both patients were administered bromocriptine; however, psychiatric symptoms did not worsen and cardiac function improved. We also review the literature on the relationship between PPCM and mental disorders. Mental disorders and psychiatric medications may be associated with the onset of peripartum cardiomyopathy (PPCM). Although bromocriptine has beneficial effects on PPCM, it has also been reported to increase the risk of worsening psychiatric symptoms; therefore, the efficacy and safety of bromocriptine in PPCM patients with mental disorders is controversial. Our cases showed that bromocriptine can be used safely without worsening psychiatric symptoms in PPCM with mental disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Paro cardiorrespiratorio secundario a miocardiopatía periparto: reporte de un caso.
- Author
-
Rodríguez Zúñiga, Jorge, Ortega Verdugo, Karen Elena, and Pacheco Zavala, Diego Ernesto
- Abstract
Copyright of Revista Médica Clínica Las Condes is the property of Editorial Sanchez y Barcelo and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
50. Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
- Author
-
Sambola, Antonia, Halvorsen, Sigrun, Adlam, David, Hassager, Christian, Price, Susanna, Rosano, Giuseppe, Schiele, Francois, Holmvang, Lene, de Riva, Marta, Rakisheva, Amina, Sulzgruber, Patrick, and Swahn, Eva
- Subjects
HEART failure ,EMERGENCY management ,PERIPARTUM cardiomyopathy ,MYOCARDIAL infarction ,ACUTE coronary syndrome ,EVIDENCE gaps ,CARDIAC arrest - Abstract
Cardiac emergencies in women, such as acute coronary syndromes, acute heart failure, and cardiac arrest, are associated with a high risk of adverse outcomes and mortality. Although women historically have been significantly underrepresented in clinical studies of these diseases, the guideline-recommended treatment for these emergencies is generally the same for both sexes. Still, women are less likely to receive evidence-based treatment compared to men. Furthermore, specific diseases affecting predominantly or exclusively women, such as spontaneous coronary dissection, myocardial infarction with non-obstructive coronary arteries, takotsubo cardiomyopathy, and peripartum cardiomyopathy, require specialized attention in terms of both diagnosis and management. In this clinical consensus statement, we summarize current knowledge on therapeutic management of these emergencies in women. Key statements and specific quality indicators are suggested to achieve equal and specific care for both sexes. Finally, we discuss several gaps in evidence and encourage further studies designed and powered with adequate attention for sex-specific analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.